LINDSEY MOORE: Open Payments
NPI 1528433844 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,844 in 64 payments from 17 companies in 2025. Trend: 2023 $739 · 2024 $573 · 2025 $6,844
Consulting: $5,608Food & beverage: $1,236
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $5,881 |
| Amgen Inc. | 1 | $175 |
| Dexcom, Inc. | 2 | $140 |
| Corcept Therapeutics | 7 | $134 |
| Bausch Health US, LLC | 4 | $71 |
| PFIZER INC. | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Lilly USA, LLC | 3 | $48 |
| ABBVIE INC. | 3 | $46 |
Products named: Wegovy, Ozempic, PROLIA, Korlym, DEXCOM G7 GSS (161), APLENZIN, VOQUEZNA, NURTEC ODT.
Industry payments across AL — which companies pay providers there.
